Vipin K. Garg
CIK: 0001515813
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Altimmune, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jan 31, 2026ALT
Altimmune, Inc.
Award(A)Direct6.9K shares at avg. $3.07$21K - Jan 30, 2026ALT
Altimmune, Inc.
Exercise(M)Direct26.8K shares- - Jan 30, 2026ALT
Altimmune, Inc.
Tax Payment(F)Direct11.6K shares at avg. $5.60$65K - Jan 27, 2026ALT
Altimmune, Inc.
Tax Payment(F)Direct17.9K shares at avg. $6.18$111K - Jan 27, 2026ALT
Altimmune, Inc.
Exercise(M)Direct41.2K shares- - Jan 25, 2026ALT
Altimmune, Inc.
Exercise(M)Direct42.1K shares- - Jan 25, 2026ALT
Altimmune, Inc.
Tax Payment(F)Direct18K shares at avg. $5.50$99K - Feb 2, 2025ALT
Altimmune, Inc.
Exercise(M)Direct19K shares- - Feb 2, 2025ALT
Altimmune, Inc.
Tax Payment(F)Direct8.3K shares at avg. $6.64$55K - Feb 1, 2025ALT
Altimmune, Inc.
Tax Payment(F)Direct7.2K shares at avg. $6.64$48K - Feb 1, 2025ALT
Altimmune, Inc.
Exercise(M)Direct16.5K shares- - Jan 31, 2025ALT
Altimmune, Inc.
Award(A)Direct4.1K shares at avg. $5.18$21K - Jan 30, 2025ALT
Altimmune, Inc.
Exercise(M)Direct26.8K shares- - Jan 30, 2025ALT
Altimmune, Inc.
Tax Payment(F)Direct11.7K shares at avg. $7.00$82K - Jan 27, 2025ALT
Altimmune, Inc.
Award(A)DirectStock Options (option to buy)
477.5K shares- - Jan 27, 2025ALT
Altimmune, Inc.
Award(A)DirectRestricted Stock Units
164.8K shares- - Jan 25, 2025ALT
Altimmune, Inc.
Tax Payment(F)Direct18.2K shares at avg. $6.98$127K - Jan 25, 2025ALT
Altimmune, Inc.
Exercise(M)Direct42.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 31, 2026 | ALT Altimmune, Inc. | Award(A) | 6,926 | $3.07 | $21,263 | Direct |
| Jan 30, 2026 | ALT Altimmune, Inc. | Exercise(M) | 26,775 | - | $0 | Direct |
| Jan 30, 2026 | ALT Altimmune, Inc. | Tax Payment(F) | 11,632 | $5.60 | $65,139 | Direct |
| Jan 27, 2026 | ALT Altimmune, Inc. | Tax Payment(F) | 17,898 | $6.18 | $110,610 | Direct |
| Jan 27, 2026 | ALT Altimmune, Inc. | Exercise(M) | 41,200 | - | $0 | Direct |
| Jan 25, 2026 | ALT Altimmune, Inc. | Exercise(M) | 42,050 | - | $0 | Direct |
| Jan 25, 2026 | ALT Altimmune, Inc. | Tax Payment(F) | 17,984 | $5.50 | $98,912 | Direct |
| Feb 2, 2025 | ALT Altimmune, Inc. | Exercise(M) | 18,950 | - | - | Direct |
| Feb 2, 2025 | ALT Altimmune, Inc. | Tax Payment(F) | 8,282 | $6.64 | $54,992 | Direct |
| Feb 1, 2025 | ALT Altimmune, Inc. | Tax Payment(F) | 7,231 | $6.64 | $48,014 | Direct |
| Feb 1, 2025 | ALT Altimmune, Inc. | Exercise(M) | 16,545 | - | - | Direct |
| Jan 31, 2025 | ALT Altimmune, Inc. | Award(A) | 4,105 | $5.18 | $21,264 | Direct |
| Jan 30, 2025 | ALT Altimmune, Inc. | Exercise(M) | 26,775 | - | - | Direct |
| Jan 30, 2025 | ALT Altimmune, Inc. | Tax Payment(F) | 11,701 | $7.00 | $81,907 | Direct |
| Jan 27, 2025 | ALT Altimmune, Inc. | Award(A) Stock Options (option to buy) | 477,500 | - | - | Direct |
| Jan 27, 2025 | ALT Altimmune, Inc. | Award(A) Restricted Stock Units | 164,800 | - | - | Direct |
| Jan 25, 2025 | ALT Altimmune, Inc. | Tax Payment(F) | 18,157 | $6.98 | $126,736 | Direct |
| Jan 25, 2025 | ALT Altimmune, Inc. | Exercise(M) | 42,050 | - | $0 | Direct |
1-18 of 18 transactions
About Garg Vipin K
Garg Vipin K (SEC CIK 0001515813) files insider reports with the SEC as Director of Altimmune, Inc. (ALT).
Signal8 holds 5 ownership filings by Garg Vipin K, all Form 4s, filed between Jan 28, 2025 and Feb 2, 2026. Those filings report 18 transactions, from Jan 25, 2025 to Jan 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Garg Vipin K's filings is in GAITHERSBURG, MD.
Recent filings by Garg Vipin K
- Jan 31, 2026: Grant or award of ALT shares (Form 4, code A).
- Jan 30, 2026: Option exercise of ALT shares (Form 4, code M).
- Jan 30, 2026: Tax withholding of ALT shares (Form 4, code F).
- Jan 27, 2026: Tax withholding of ALT shares (Form 4, code F).
- Jan 27, 2026: Option exercise of ALT shares (Form 4, code M).
Other insiders filing for Altimmune, Inc. (ALT)
- Greenleaf Peter, Officer
- Howarth Alex G., Officer
- Arbet-Engels Christophe, Chief Medical Officer
- WEAVER GREGORY L, Chief Financial Officer
- MENZIUSO RICHARD THOMAS, Principal Accounting Officer
- Richardson Linda M, Chief Commercial Officer